RedHill Biopharma reported 7.1M in Interest Income for its fiscal quarter ending in June of 2023.


Interest Income Change Date
Compugen 1.07M 1.39M Jun/2025
Cronos Group USD 9M 668K Jun/2025
RedHill Biopharma 7.1M 14.49M Jun/2023